gilead sciences inc (GILD:NASDAQ GS)
2013 SEC Filings - gilead sciences inc (GILD)
2012 SEC Filings - gilead sciences inc (GILD)
2011 SEC Filings - gilead sciences inc (GILD)
2010 SEC Filings - gilead sciences inc (GILD)
| Recently Viewed | |||
| GILD:US | $56.30 USD | 0.00 | |
| Company | Last | Change |
| AbbVie Inc | $47.17 USD | 0.00 |
| Amgen Inc | $105.63 USD | 0.00 |
| Astellas Pharma Inc | ¥5,700 JPY | -130.00 |
| Bristol-Myers Squibb Co | $43.30 USD | 0.00 |
| Eli Lilly & Co | $55.90 USD | 0.00 |
| View Industry Companies | ||
Industry Analysis
GILD
Industry Average
| Valuation | GILD | Industry Range |
| Price/Earnings | 30.8x |
|
| Price/Sales | 8.4x |
|
| Price/Book | 8.3x |
|
| Price/Cash Flow | 29.2x |
|
| TEV/Sales | 7.4x |
|
Post a JobJobs
- San Dimas, CA | Gilead SciencesPosted: May 18
- Foster City, CA | Gilead SciencesPosted: May 18
- San Dimas, CA | Gilead SciencesPosted: May 18
- Foster City, CA | Gilead SciencesPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.













